Sotera Health Company (SHC) key performance indicators and operating metrics (11 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Adjusted diluted earnings per share | 0.18 USD_per_share | FY2026-Q1 |
| Net revenues growth YoY | 10.00 percent | FY2026-Q1 |
| Nelson Labs net revenues | 51.9M | FY2026-Q1 |
| Nordion net revenues | 42.01M | FY2026-Q1 |
| Sterigenics net revenues | 186.14M | FY2026-Q1 |
| Sterigenics segment income | 96.41M | FY2026-Q1 |
| Nordion segment income | 23.71M | FY2026-Q1 |
| Adjusted earnings before interest taxes depreciation and amortization growth YoY | 10.50 percent | FY2026-Q1 |
| Net revenues growth constant currency YoY | 6.50 percent | FY2026-Q1 |
| Adjusted earnings before interest taxes depreciation and amortization | 157M | FY2025-Q4 |
| Nelson Labs segment income | 18M | FY2025-Q4 |
Back to SHC overview · SHC earnings · SHC holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.